Skip to main content
Clinical Trials/NCT05102227
NCT05102227UnknownNot Applicable

Cardiac ResynchronizatiOn and arrhythmiaS Sensing Via the LEFT Bundle. The CROSS LEFT Study.

University Hospital, Tours1 site in 1 country10 target enrollmentStarted: March 25, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
10
Locations
1
Primary Endpoint
Number of patients with successful defibrillation at 35 Joules.

Study Overview

Brief Summary

Evaluation of ventricular arrhythmias sensing via a left bundle branch area pacing lead.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Ischemic or non-ischemic cardiomyopathy
  • Left ventricular ejection fraction ≤35% despite optimal medical therapy
  • Left bundle branch block with QRS ≥130 milliseconds

Exclusion Criteria

  • Previously implanted intra-cardiac material

Outcomes

Primary Outcomes

Number of patients with successful defibrillation at 35 Joules.

Time Frame: 24 hours

After manual induction of ventricular fibrillation, a 35 Joules will be delivered with the implanted defibrillator.

Secondary Outcomes

  • Time from ventricular fibrillation induction to defibrillation shock.(24 hours)
  • Number of appropriate and inappropriate arrhythmic episodes.(6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Nicolas Clementy, MD, PhD

Associate Professor

University Hospital, Tours

Study Sites (1)

Loading locations...

Similar Trials

Cardiac ResynchronizatiOn and arrhythmiaS... | Clinical Trial